Bentham Science Logo

Current Drug Safety

Volume 14, 3 Issues, 2019
ISSN: 2212-3911 (Online)
ISSN: 1574-8863 (Print)
This journal supports open access

Most Cited Articles

Review Article

Risks associated with SGLT2 inhibitors: An overview

, 2018; 13(2): 84-91.

Mahakpreet Singh and Anoop Kumar*


DOI: 10.2174/1574886313666180226103408



Case Studies

A probable topiramate-induced limbs paraesthesia and rigid fingers flexion

, 2018; 13(2): 131-136.

Andrea Domenico Pratico*, Martino Ruggieri, Raffaele Falsaperla and Piero Pavone


DOI: 10.2174/1574886313666180213090445


Case Studies

Dolutegravir-related neurological adverse events: A case report of successful management with therapeutic drug monitoring

, 1 March 2018; 13(1): 69-71.

Francois Parant*, Patrick Miailhes, Florence Brunel and Marie-Claude Gagnieu


DOI: 10.2174/1574886313666180116124046


Review Article

Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature

, 2018; 13(3): 150-164.

Devis Benfaremo, Lucia Manfredi , Michele Maria Luchetti* and Armando Gabrielli


DOI: 10.2174/1574886313666180508122332



Review Article

Vaping versus smoking: A quest for efficacy and safety of E-cigarette

, 2018; 13(2): 92-101.

Harmeet Singh Rehan*, Jahnavi Maini and Amrit Pal Singh Hungin


DOI: 10.2174/1574886313666180227110556


Research Article

Safety of vinflunine in patients with advanced urothelial carcinoma refractory to platinum-based chemotherapy: A prospective pilot study

, 2019; 14(1): 31-36.

Raafat Abdel-Malek, Kyrillus S. Shohdy*, Noha Abbas, Mohamed Ismail, Emad Hamada and Yasser Abdel-Kader


DOI: 10.2174/1574886313666181001120752



Review Article

Cutaneous adverse events of immune checkpoint inhibitors: A summarized overview

, 2019; 14(1): 14-20.

Kerasia-Maria Plachouri *, Eleftheria Vryzaki and Sophia Georgiou


DOI: 10.2174/1574886313666180730114309


Case Report

Biperiden-induced delirium in a five-years old child

, 2019; 14(1): 48-50.

Duygu Kınay and Ahmet Zihni Soyata*


DOI: 10.2174/1574886313666181029101830




Case Studies

Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study

, 2018; 13(3): 200-207.

Andrea D. Pratico*, Laura Longo, Silvana Mansueto, Lucia Gozzo, Ignazio Barberi, Venera Tiralongo, Vincenzo Salvo, Raffaele Falsaperla, Giovanna Vitaliti, Mario La Rosa, Salvatore Leonardi, Antonio Rotondo, Nicoletta Avola, Debora Sgarlata, Annalisa Damiano, Massimo Tirantello, Gaspare Anzelmo, Domenico Cipolla, Angelo Rizzo, Antonio Russo, Martino Ruggieri, Salvatore Salomone and Filippo Drago


DOI: 10.2174/1574886313666180619120406


Research Article

Register-based ecologic evaluation of safety signals related to pneumococcal conjugate vaccine in children

, 2018; 13(2): 107-112.

Miia Artama*, Hanna Rinta-Kokko, Hanna Nohynek, Jukka Jokinen and Arto A. Palmu


DOI: 10.2174/1574886313666180406164151




Editor-in-Chief

Dr. Seetal Dodd
University of Melbourne
Geelong, Melbourne
Australia

Biography View Full Editorial Board

Journal History

Current Drug Safety Journal was launched in 2006. Dr. Seetal Dodd serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog